Literature DB >> 24785792

Searching for the new normal: exploring the role of language and metaphors in becoming a cancer survivor.

Lynda Appleton1, Maria Flynn2.   

Abstract

PURPOSE: This qualitative exploratory study was grounded in local patient and service user experiences and was designed to investigate how the language and metaphors of cancer influence personal and social adjustment after completion of a course of treatment.
METHODS: The study employed a focus group design, in which eighteen people, recruited through regional networks and support groups, participated. Meetings elicited participants' stories and focused discussion on key words and common phrases in the cancer lexicon. Data from transcribed focus group recordings were analysed thematically and organised into descriptive categories concerned with the interpretations of common terms and how these influenced the management of identity and emotions.
RESULTS: The thematic categories emphasised the importance of language in the way participants managed their illness and sought to control their feelings and their interactions with others. Interpretation of findings revealed a strong central idea linking participants' accounts, which was that language, metaphor and euphemism are central to adjustment and the forging of an altered identity as a survivor of cancer diagnosis and treatment.
CONCLUSIONS: The findings are consistent with what is already known about the language and metaphors of cancer, with language being an important mechanism for managing uncertainty. From participants' accounts it also appears that there may be subtle but important differences in professional and lay understandings of cancer language and metaphor. This suggests a need for oncology nurses to elaborate their broad understanding of communication skills and move toward a more detailed understanding of the language used during interactions with patients.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer language; Focus group method; Metaphor; Oncology nursing; Survivor; Survivorship

Mesh:

Year:  2014        PMID: 24785792     DOI: 10.1016/j.ejon.2014.03.012

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  7 in total

1.  Using Metaphors to Explain Molecular Testing to Cancer Patients.

Authors:  Ana P M Pinheiro; Rachel H Pocock; Margie D Dixon; Walid L Shaib; Suresh S Ramalingam; Rebecca D Pentz
Journal:  Oncologist       Date:  2017-02-20

2.  "Special needs" is an ineffective euphemism.

Authors:  Morton Ann Gernsbacher; Adam R Raimond; M Theresa Balinghasay; Jilana S Boston
Journal:  Cogn Res Princ Implic       Date:  2016-12-19

3.  Patient, cured, victim or survivor of urological cancer? A qualitative study.

Authors:  Rafaela Azevedo Abrantes de Oliveira; Márcia Maria Fontão Zago
Journal:  Rev Lat Am Enfermagem       Date:  2018-11-29

4.  Understanding Youth's Lived Experience of Anxiety through Metaphors: A Qualitative, Arts-Based Study.

Authors:  Roberta Lynn Woodgate; Pauline Tennent; Nicole Legras
Journal:  Int J Environ Res Public Health       Date:  2021-04-19       Impact factor: 3.390

5.  "Your Ovaries Are Expired, Like an Old Lady" Metaphor Analysis of Saudi Arabian Women's Descriptions of Breast Cancer: A Qualitative Study.

Authors:  Wafa Hamad Almegewly; Maha Hamed Alsoraihi
Journal:  Front Psychol       Date:  2022-07-22

6.  Quality of Patient-Provider Communication Among Cancer Survivors: Findings From a Nationally Representative Sample.

Authors:  Neetu Chawla; Danielle Blanch-Hartigan; Katherine S Virgo; Donatus U Ekwueme; Xuesong Han; Laura Forsythe; Juan Rodriguez; Timothy S McNeel; K Robin Yabroff
Journal:  J Oncol Pract       Date:  2016-10-31       Impact factor: 3.840

7.  The existence and importance of patients' mental images of their head and neck cancer: A qualitative study.

Authors:  Heidi Lang; Emma F France; Brian Williams; Gerry Humphris; Mary Wells
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.